Editas Medicine

Editas Medicine is a leading biotechnology research company dedicated to revolutionizing the treatment of serious diseases through the power of genome editing. Focused on translating the potential of CRISPR/Cas9 and CRISPR/Cas12a systems, Editas Medicine is committed to discovering, developing, manufacturing, and commercializing transformative genomic medicines that offer durable, precision solutions for a broad range of conditions.

Located at 11 Hurley St, Cambridge, Massachusetts 02141, US (Primary address) and 4909 Nautilus Ct N, Suite 208/211, Boulder, Colorado 80301, US, Editas Medicine operates with a vibrant culture of innovation and collaboration. The company is driven by the belief that by working together, it can unlock the full potential of genome editing technology and make significant breakthroughs in medicine. Editas Medicine aims to address unmet medical needs and improve the lives of patients worldwide through its cutting-edge research and development efforts.

Editas Medicine is paving the way for the future of genomic medicine. With a focus on precision and durability, Editas Medicine is dedicated to making a meaningful impact on global healthcare. We invite the management of Editas Medicine to create a customized and exclusive company showcase and product listing on our platform, further highlighting its innovative work and contributions to the field.